GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementGalectin Therapeutics Inc • May 19th, 2017 • Pharmaceutical preparations • New York
Company FiledMay 19th, 2017 Industry JurisdictionGalectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with FBR Capital Markets & Co. (“FBR”), as follows: